Positive results in trials of Alzheimer’s treatment
In latest trials, the NeuroAD cranial device from Israel’s Neuronix (see here) slowed the progression of the disease in 85% of patients suffering mild Alzheimer’s. The treatment is now being used commercially in the UK (London, Berkshire, Chester and Manchester).
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink